HomeCompareLBAI vs PFE

LBAI vs PFE: Dividend Comparison 2026

LBAI yields 4.32% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LBAI wins by $28.0K in total portfolio value
10 years
LBAI
LBAI
● Live price
4.32%
Share price
$13.43
Annual div
$0.58
5Y div CAGR
30.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$79.1K
Annual income
$19,142.00
Full LBAI calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — LBAI vs PFE

📍 LBAI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLBAIPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LBAI + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LBAI pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBAI
Annual income on $10K today (after 15% tax)
$367.09/yr
After 10yr DRIP, annual income (after tax)
$16,270.70/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PFE beats the other by $6,858.26/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBAI + PFE for your $10,000?

LBAI: 50%PFE: 50%
100% PFE50/50100% LBAI
Portfolio after 10yr
$65.1K
Annual income
$23,176.27/yr
Blended yield
35.61%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

LBAI
Analyst Ratings
7
Buy
4
Hold
Consensus: Buy
Price Target
$20.00
+48.9% upside vs current
Range: $20.00 — $20.00
Altman Z
-0.8
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBAI buys
0
PFE buys
0
No recent congressional trades found for LBAI or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLBAIPFE
Forward yield4.32%6.20%
Annual dividend / share$0.58$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.7%13.2%
Portfolio after 10y$79.1K$51.1K
Annual income after 10y$19,142.00$27,210.54
Total dividends collected$52.1K$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold
Analyst price target$20.00$27.50

Year-by-year: LBAI vs PFE ($10,000, DRIP)

YearLBAI PortfolioLBAI Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,264$564.45$9,161$701.38+$2.1KLBAI
2$12,830$776.66$8,610$859.79+$4.2KLBAI
3$14,808$1,080.50$8,366$1,081.25+$6.4KLBAI
4$17,368$1,523.37$8,483$1,405.66+$8.9KLBAI
5$20,766$2,182.47$9,084$1,907.24+$11.7KLBAI
6$25,408$3,187.48$10,418$2,732.78+$15.0KLBAI
7$31,950$4,763.66$13,007$4,193.56+$18.9KLBAI
8$41,503$7,317.06$18,010$7,005.87+$23.5KLBAI
9$56,019$11,610.31$28,216$12,979.89+$27.8KLBAI
10$79,082$19,142.00$51,081$27,210.54+$28.0KLBAI

LBAI vs PFE: Complete Analysis 2026

LBAIStock

Lakeland Bancorp, Inc. operates as the bank holding company for Lakeland Bank that offers various banking products and services for individuals and small to medium sized businesses. The company provides commercial banking services, including savings, money market, and time accounts, as well as demand deposits. It is also involved in lending services, including commercial real estate loans, commercial and industrial loans, short and medium term loans, lines of credit, letters of credit, inventory and accounts receivable financing, real estate construction loans, residential mortgage loans, Small Business Administration (SBA) loans, and merchant credit card services; financing solutions to small and medium-sized companies; online banking, mobile banking, and wire transfer services; and cash management services, such as remote capture of deposits and overnight sweep repurchase agreements. In addition, it provides consumer banking services, which include checking accounts, savings accounts, interest-bearing checking accounts, money market accounts, certificates of deposit, online banking, secured and unsecured loans, consumer installment loans, mortgage loans, and safe deposit services. Further, the company offers investment advisory services for individuals and businesses; and securities brokerage services, including mutual funds and variable annuities, as well as commercial title insurance services and life insurance products. As of December 31, 2021, it operated 48 branch offices located throughout Bergen, Essex, Morris, Ocean, Passaic, Somerset, Sussex, and Union counties in New Jersey and in Highland Mills, New York; operated six New Jersey regional commercial lending centers in Bernardsville, Iselin, Jackson, Montville, Teaneck and Waldwick; and one New York commercial lending center to serve the Hudson Valley region. The company was incorporated in 1969 and is headquartered in Oak Ridge, New Jersey.

Full LBAI Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this LBAI vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBAI vs SCHDLBAI vs JEPILBAI vs OLBAI vs KOLBAI vs MAINLBAI vs JNJLBAI vs MRKLBAI vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.